Treatment Considerations for the Management of Fibrodysplasia Ossificans Progressiva
Publication type: Journal Article
Publication date: 2005-10-01
wos Q3
SJR: —
CiteScore: —
Impact factor: 2.0
ISSN: 15348644, 15590119
Endocrinology
Endocrinology, Diabetes and Metabolism
Orthopedics and Sports Medicine
Abstract
The ultimate goal of research on fibrodysplasia ossificans progressiva (FOP) is the development of treatments that will prevent, half, or even reverse the progression of the condition. Despite advances in understanding the pathophysiology of FOP, there are no therapies with scientifically proven benefits for the prevention or treatment of FOP. Insights obtained from the research laboratory and from the treatment of hundreds of patients world wide have allowed us to identify targets for potential therapies. Some of these therapies involve the use of currently available medications, whereas others involve novel therapeutic approaches that are in preclinical testing. In this article, we will review the scientific basis for considering various therapeutic options based on the known pathophysiology of FOP. Because there are presently no proven preventions or treatments for the condition, this article is intended to represent an opinion of the authors that may be helpful to others who face similar situations.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
|
|
|
Journal of Oral and Maxillofacial Surgery
3 publications, 8.57%
|
|
|
Journal of Bone and Joint Surgery - Series A
2 publications, 5.71%
|
|
|
Journal of Bone and Mineral Metabolism
2 publications, 5.71%
|
|
|
Bone
2 publications, 5.71%
|
|
|
Intractable and Rare Diseases Research
1 publication, 2.86%
|
|
|
Pediatrics
1 publication, 2.86%
|
|
|
Pediatrics in Review
1 publication, 2.86%
|
|
|
Clinical Orthopaedics and Related Research
1 publication, 2.86%
|
|
|
Journal of Neurosurgery: Spine
1 publication, 2.86%
|
|
|
Journal of Neurosurgery: Pediatrics
1 publication, 2.86%
|
|
|
Rheumatology International
1 publication, 2.86%
|
|
|
European Journal of Pediatrics
1 publication, 2.86%
|
|
|
Indian Journal of Orthopaedics
1 publication, 2.86%
|
|
|
Topics in Companion Animal Medicine
1 publication, 2.86%
|
|
|
Best Practice and Research in Clinical Rheumatology
1 publication, 2.86%
|
|
|
Archives de Pediatrie
1 publication, 2.86%
|
|
|
Anales de Pediatria
1 publication, 2.86%
|
|
|
Morphologie
1 publication, 2.86%
|
|
|
Anatomical Record
1 publication, 2.86%
|
|
|
Journal of Pathology
1 publication, 2.86%
|
|
|
Journal of Bone and Mineral Research
1 publication, 2.86%
|
|
|
Human Mutation
1 publication, 2.86%
|
|
|
Expert Opinion on Biological Therapy
1 publication, 2.86%
|
|
|
Australasian Journal of Ultrasound in Medicine
1 publication, 2.86%
|
|
|
Annals of Translational Medicine
1 publication, 2.86%
|
|
|
Southern African Journal of Anaesthesia and Analgesia
1 publication, 2.86%
|
|
|
1
2
3
|
Publishers
|
2
4
6
8
10
12
|
|
|
Elsevier
11 publications, 31.43%
|
|
|
Wiley
6 publications, 17.14%
|
|
|
Springer Nature
5 publications, 14.29%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
3 publications, 8.57%
|
|
|
American Academy of Pediatrics
2 publications, 5.71%
|
|
|
Journal of Neurosurgery Publishing Group (JNSPG)
2 publications, 5.71%
|
|
|
Taylor & Francis
2 publications, 5.71%
|
|
|
International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)
1 publication, 2.86%
|
|
|
AME Publishing Company
1 publication, 2.86%
|
|
|
2
4
6
8
10
12
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
35
Total citations:
35
Citations from 2024:
0
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Glaser D. L. et al. Treatment Considerations for the Management of Fibrodysplasia Ossificans Progressiva // Clinical Reviews in Bone and Mineral Metabolism. 2005. Vol. 3. No. 3-4. pp. 243-250.
GOST all authors (up to 50)
Copy
Glaser D. L., Kaplan F. S. Treatment Considerations for the Management of Fibrodysplasia Ossificans Progressiva // Clinical Reviews in Bone and Mineral Metabolism. 2005. Vol. 3. No. 3-4. pp. 243-250.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1385/bmm:3:3-4:243
UR - https://doi.org/10.1385/bmm:3:3-4:243
TI - Treatment Considerations for the Management of Fibrodysplasia Ossificans Progressiva
T2 - Clinical Reviews in Bone and Mineral Metabolism
AU - Glaser, David L.
AU - Kaplan, Frederick S.
PY - 2005
DA - 2005/10/01
PB - Springer Nature
SP - 243-250
IS - 3-4
VL - 3
SN - 1534-8644
SN - 1559-0119
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2005_Glaser,
author = {David L. Glaser and Frederick S. Kaplan},
title = {Treatment Considerations for the Management of Fibrodysplasia Ossificans Progressiva},
journal = {Clinical Reviews in Bone and Mineral Metabolism},
year = {2005},
volume = {3},
publisher = {Springer Nature},
month = {oct},
url = {https://doi.org/10.1385/bmm:3:3-4:243},
number = {3-4},
pages = {243--250},
doi = {10.1385/bmm:3:3-4:243}
}
Cite this
MLA
Copy
Glaser, David L., et al. “Treatment Considerations for the Management of Fibrodysplasia Ossificans Progressiva.” Clinical Reviews in Bone and Mineral Metabolism, vol. 3, no. 3-4, Oct. 2005, pp. 243-250. https://doi.org/10.1385/bmm:3:3-4:243.